A 3D View: Janus Kinase Inhibition as a Novel Approach to Rheumatoid Arthritis: Emerging Data Impacting Our Treatment Paradigms

                                                                                                      3D Satellite Symposium

This symposium will be conducted in conjunction with the 2017 ACR/ARHP Annual Meeting

REGISTER NOW!
Already Registered?
SIGN IN

WEBCAST DATE

TUESDAY, NOVEMBER 7, 2017

10:00 PM Eastern   9:00 PM Central   8:00 PM Mountain   7:00 PM Pacific

PROGRAM FEATURES

~ 1.5 CME CREDITS
~ 3D Glasses Provided to All Attendees
~ Create your own personalized poster
~ Ipads provided to enhance learning experience
~ Interactive, case-based learning environment

FACULTY

Maria Greenwald, MD
Director
Desert Medical Advances
Palm Desert, CA

Gregg J. Silverman, MD
Professor of Medicine and Pathology
Director, Laboratory of B cell Immunobiology
NYU School of Medicine
New York, NY

PROGRAM AGENDA

I. Pathophysiology of rheumatoid arthritis (RA)
II. Current and emerging therapeutic targets in RA: 
  • 3D video—RA pathophysiology: focus on cytokines as cellular mediators of chronic inflammation
III. Inhibitors of intracellular cytokines signaling: targeting the JAK-STAT pathway as new therapeutic strategy in RA
  • 3D video— JAK-STAT inhibition in RA
IV. JAK inhibitors: efficacy and safety in RA
  • ​What special opportunities do they offer?
    - How do they differ from each other?
V. Interactive case studies
VI. Conclusions

EDUCATIONAL OBJECTIVES

After completing the CME activity, learners should be better able to:

• Review current understanding of rheumatoid arthritis (RA) pathophysiology with focus on the cytokine signaling pathways underlying chronic inflammation.
• Describe how specific cytokines involved in RA pathophysiology signal through the Janus kinase (JAK) pathway and the mechanism of action, selectivity, and effects of new and emerging JAK inhibitors.
• Discuss new data from clinical trials of approved and investigational JAK inhibitors and their efficacy/safety profiles across the spectrum of RA.

TARGET AUDIENCE

This CME initiative is designed to meet the educational needs of rheumatologists, rheumatology nurses and other healthcare providers involved in the treatment of patients with rheumatoid arthritis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of patients with rheumatoid arthritis.

Credits:
1.5 ANCC Contact Hour(s)

Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This symposium will be conducted in conjunction with the 2017 ACR/ARHP Annual Meeting

Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.